Characteristics | CDK11p58 | ||||
---|---|---|---|---|---|
Low | High | n | x 2 | p | |
Age(years) | 7.024 | 0.008 | |||
<50 | 27(8.1%) | 78(31.5%) | 105 | ||
≥50 | 18(7.3%) | 125(50.4%) | 143 | ||
Menopausal status | 0.375 | 0.540 | |||
Pre | 29(11.6%) | 122(48.8%) | 151 | ||
Post | 16(6.4%) | 83(33.2%) | 99 | ||
Tumor size (cm) | 0.939 | 0.333 | |||
≦2 cm | 18(7.4%) | 95(39.1%) | 113 | ||
>2 cm | 27(11.1%) | 103(42.4%) | 130 | ||
Node status | 6.312 | 0.012 | |||
Negative | 18(7.2%) | 124(49.6%) | 142 | ||
Positive | 27(10.8%) | 81(32.4%) | 108 | ||
ER status | 4.065 | 0.044 | |||
Negative | 33(13.2) | 117(46.8%) | 150 | ||
Positive | 12(4.8%) | 88(35.2) | 100 | ||
HER-2 status | 2.823 | 0.093 | |||
Negative | 22(8.8%) | 128(51.2%) | 150 | ||
Positive | 23(9.2%) | 77(30.8) | 100 | ||
Differentiation | 1.456 | 0.228 | |||
III | 26(13.7%) | 142(74.7%) | 130 | ||
III | 14(7.4%) | 49(25.8%) | 60 | ||
TNM stage | 1.567 | 0.211 | |||
III | 23(11%) | 129(61.4%) | 152 | ||
III | 13(6.2%) | 45(21.4%) | 58 | ||
Relapse | 9.323 | 0.002 | |||
No | 29(11.8%) | 179(72.8%) | 208 | ||
Yes | 13(5.3%) | 25(10.2%) | 38 | ||
Metastasis | 4.803 | 0.023 | |||
No | 26(10.6%) | 159(64.6%) | 185 | ||
Yes | 16(6.5%) | 45(18.3%) | 61 |